Organigram Holdings (NASDAQ: OGI) reported Q2 EPS of ($0.041), versus ($0.049) reported last year. Revenue for the quarter came in at $23.2 million, versus $25.2 million reported last year.

• Net revenue of $23.2 million compared to $26.9 million in Q2 2019 and $25.2 million in Q1 2020
• Adult-use recreational net revenue sequentially grew 16% to $15.0 million from $12.9 million in Q1 2020
• Ended quarter with $41.2 million in cash and short-term investments
• First shipped its Rec 2.0 products with Trailblazer Torch vape cartridges in December 2019, followed by Edison Feather ready-to-go distillate vape pens and Edison Bytes, cannabis-infused chocolates, in February 2020
• Expect Edison PAX ERA distillate cartridges to start shipping in Q2 calendar 2020
• Subsequent to quarter-end, received licensing for the remainder of Phase 5, which includes a dedicated edibles and derivatives facility
• Announced a corporate action plan intended to boost containment of the COVID-19 virus and protect the health of employees as well as maintain sufficient business continuity to meet anticipated demand for its products during this period

“Our second quarter results reflect continued execution despite ongoing industry challenges,” said Greg Engel, CEO. “We introduced new products such as our Edison Bytes chocolates, Edison Limelight dried flower and Trailblazer vape pens and continue to elevate the Canadian consumer’s cannabis experience. These products have been well received with strong customer demand to date and we look forward to further roll-outs in the space.”

For earnings history and earnings-related data on Organigram Holdings (OGI) click here.